2023-03-28 07:54:10 ET
- Vera Therapeutics press release ( NASDAQ: VERA ): FY GAAP EPS of -$3.35 misses by $0.34 .
- Vera reported $114.7 million in cash, cash equivalents, and marketable securities as of December 31, 2022. Subsequent to December 31, 2022, the company raised approximately $107.6 million in net proceeds, after deducting underwriting discounts and commissions and offering expenses, from a public offering of its Class A common stock that was completed in February 2023.
For further details see:
Vera Therapeutics GAAP EPS of -$3.35 misses by $0.34